Camurus AB (publ) (STO:CAMX)
Sweden
· Delayed Price · Currency is SEK 480.80
0.00 (0.00%)
At close: Mar 6, 2026
Camurus AB Employees
Camurus AB had 285 employees as of December 31, 2025. The number of employees increased by 29 or 11.33% compared to the previous year.
Employees
285
Change (1Y)
29
Growth (1Y)
11.33%
Revenue / Employee
7.95M SEK
Profits / Employee
2.58M SEK
Market Cap
28.70B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioArctic AB | 131 |
| Hansa Biopharma AB | 125 |
| Flerie AB | 9 |
| Vicore Pharma Holding AB | 36 |
| Egetis Therapeutics AB | 40 |
| Diamyd Medical AB | 41 |
| Saniona AB | 31 |
| BioInvent International AB | 109 |
Camurus AB News
- 23 days ago - Camurus AB (CAMRF) Q4 2025 Earnings Call Highlights: Strong Financial Performance and Strategic ... - GuruFocus
- 23 days ago - Q4 2025 Camurus AB Earnings Call Transcript - GuruFocus
- 4 months ago - Camurus reports positive topline results for CAM2056, semaglutide monthly depot - PRNewsWire
- 9 months ago - Camurus' POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients - PRNewsWire
- 9 months ago - Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins - PRNewsWire
- 11 months ago - CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU - PRNewsWire
- 1 year ago - US FDA declines to approve Camurus' rare hormone disorder drug - Reuters
- 1 year ago - New publication shows effectiveness data for weekly and monthly buprenorphine injections in treating opioid dependence in individuals using fentanyl - PRNewsWire